← Human Trials & Peer-Reviewed Studies

Feasibility and acceptability of Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy multicomponent implementation intervention and study design for Australian Indigenous pregnant women: A pilot cluster randomised step-wedge trial.

Plain-language guide to PMID 30412909 (2019): pilot randomized controlled trial of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID
30412909
Journal
Addictive behaviors
Year
2019
Study type
Randomized Controlled Trial
Authors
Gould GS et al. (12 authors)
DOI
10.1016/j.addbeh.2018.10.036

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a randomized controlled trial.

Many health providers (HPs) lack knowledge, confidence, optimism and skills in addressing smoking with pregnant women.

This study aimed to explore the feasibility and acceptability of a) a co-designed multi-component intervention for HPs at Aboriginal Medical Services (AMSs) in culturally-targeted pregnancy-specific smoking cessation care and b) the study design.

Who Took Part

By PubMed's age tags, the people studied were young adults and adults, women only.

HPs were provided educational resource packages including live interactive webinars, treatment manuals, patient resources, carbon monoxide (CO) meters, and oral Nicotine Replacement Therapy (NRT).

How the Study Was Run

The researchers set it up as a randomized and pilot study.

Random assignment meant chance, not the researchers, decided who got Therapeutic nicotine (patch, non-peptide) and who got the comparison, which limits bias.

It is described as a pilot, a small early test of whether a larger Therapeutic nicotine (patch, non-peptide) study would be practical.

Using a randomised step-wedge cluster design, the Indigenous Counselling And Nicotine (ICAN) QUIT in Pregnancy Trial was evaluated across six AMSs in three Australian states.

Qualitative interviews with staff post-trial explored acceptability of the intervention and study, based on capability, opportunity and motivation from the Behaviour Change Wheel.

What Was Measured

The subject headings attached to it are Australia, Cluster Analysis, Counseling, Feasibility Studies, Patient Acceptance of Health Care, Pilot Projects and Pregnant People.

Author keywords: Behaviour change wheel, COM-B model, Health provider training, Indigenous populations, Nicotine replacement therapy and Pregnancy.

What This Means in Plain Language

The paper is a randomized and pilot study of Therapeutic nicotine (patch, non-peptide).

Its findings take up roughly 12 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2019 (Addictive behaviors), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.